HLA-DRB1 and chronic myelogenous leukemia, BCR-ABL1 positive: Notably, a study by Morsi et al. [80] highlights that the combined involvement of HLA-DRB1*11 and HLA-DRB1*15 alleles in predicting an unfavorable response to therapy in acute and chronic myeloid leukemia.